Angiotensin converting enzyme gene polymorphism and its association with hypertension in South Indian population

Indian Journal of Clinical Biochemistry

Volumn 27, Issue 3, 2012, Pages 265-269

  Choudhury, Ipsita ^a   Jothimalar, R ^b   Patra, Arun Kumar ^c  

^a HOSPITAL AND RESEARCH CENTRE   (India)

^b SRI RAMACHANDRA UNIVERSITY   (India)

^c ARMED FORCES MEDICAL COLLEGE   (India)

Author keywords

Angiotensin converting enzyme (ACE); Hypertension; Polymerase chain reaction (PCR); Renin angiotensin system

Indexed keywords

AGAROSE; DIPEPTIDYL CARBOXYPEPTIDASE;

ADULT; AGED; ALU SEQUENCE; ARTICLE; CARDIAC PATIENT; CARDIOVASCULAR RISK; CONTROLLED STUDY; DISEASE ASSOCIATION; DNA POLYMORPHISM; GENE AMPLIFICATION; GENE DELETION; GENE INSERTION; GENOTYPE; HETEROZYGOSITY; HOMOZYGOSITY; HUMAN; HYPERTENSION; INDIAN; INTRON; MAJOR CLINICAL STUDY; PATHOPHYSIOLOGY; PILOT STUDY; POLYMERASE CHAIN REACTION; POPULATION RESEARCH; STATISTICAL ANALYSIS;

EID: 84864474089     PISSN: 09701915     EISSN: 09740422     Source Type: Journal    
DOI: 10.1007/s12291-012-0217-8     Document Type: Article

References (32)

1. Kannel WB, Wilson PWF. Cardiovascular risk factors and hypertension. In: Izzo Jl, Black H, editors. Hypertension primer (Second edition): The essentials of high blood pressure. 1999;335:765-774.
2. Lindpaintner K, Ganten D. Tissue renin angiotensin system and their modulation: the heart as a paradigm for new aspects of converting enzyme inhibition. Cardiology. 1991;79 suppl:32-44.
3. Griendling KK, Murphy TW. Molecular biology of renin angiotensin system. Circulation. 1993;87:1810-28.
4. Neuringer IR, Brenner BM. Hemodynamic theory of progressive renal disease-A 10 yr updates in brief review. Am J Kidney Dis. 1993;22:98-104.
5. Navar LG, Lewis L, Hymel A. Tubular fluid concentrations and kidney contents of angiotensins I and II in anesthetized rats. J Am Soc Nephrol. 1994;5:1153-8.
6. Atiyeh BA, Arant BS Jr, Henrich WL. In vitro production of angiotensin II by isolated glomeruli. Am J Physiol Renal. 1995;268:F266-72.
7. Urata H, Nishimura H, Ganten D. Mechanism of angiotensin II formation in humans. Eur Heart J. 1995;16:79-85.
8. Zitnay C, Siragy HM. Action of angiotensin receptor subtypes on the renal tubules and vasculature: implications for volume homeostasis and atherosclerosis. Miner Electrolyte Metab. 1998;24:362-70.
9. Siragy HM. AT1 and AT2 receptors in the kidney: role in disease and treatment. Am J Kidney Dis. 2000;36:S4-90.
10. Hubert C, Houot AM, Corvol P. Association between ACE gene I/D polymorphism and primary hypertension in Turkish patients of Trakya region. Biol Chem. 1991;266:15377-83.
11. Mattei MG, Hubert C, Alhenc F. ACE gene is on chromosome 17. Cytogenet Cell Genet. 1989;51:1041-5.
12. Rigat B, Hubert C, Corvol P. Serum ACE levels in D/D genotype. Nucleic Acids Res. 1992;20:143.
13. Rigat B, Hubert C, Alhenc gelas F. An insertion/deletion polymorphism in the ACE gene accounting for half the variance of serum enzyme levels. J Clin Invest. 1990;86:1343-6.
14. Jeffers BW, Estacio RO, Raynolds MV. Angiotensin converting enzyme polymorphism in non insulin dependent diabetes mellitus and its relationship with diabetic nephropathy. Kidney Int. 1997;52:473-7.
15. Marre M, Jeunemaitre X, Gallois Y. Contribution of genetic polymorphism in the renin angiotensin system to the development of renal complication in IDDM. J Clin Invest. 1997;99:1585-95.
16. Mulder HJGH, van Geel PP, Schalij MJ, van Gilst WH, Zwinderman AH, Bruschke AVG. DD ACE gene polymorphism is associated with increased coronary artery endothelial dysfunction. Heart. 2003;89:557-8.
17. Takemoto Yuji, Sakatini Mitsunori, Takani Seijyu. Association between AII receptor gene polymorphism and serum ACE activity in patients with sarcoidosis. Thorax. 1998;53:549-62.
18. Chobain AV. The Seventh report of joint national committee on prevention, detection, evaluation and treatment of high blood pressure. The JNC & report. JAMA. 2003;289:2560-72.
19. Miller SA, Dykes DD, Polesky HF. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res. 1998;16:1215.
20. Gupta R. Trends in hypertension. Epidemiology in India. Hum Hypertens. 2004;18:73-8.
21. Chaturvedi N. Ethnic differences in cardiovascular disease. Heart. 2003;89:681-6.
22. Manunta Paolo. Are the new single nucleotide polymorphisms relevant for hypertensive populations? J Hypertens. 2002;20(12):2335-6.
23. Thiol B, Weber AB. Genes for essential hypertension. Hype, help or hope? J Clin Hypertens (Greenwich). 2002;2:187-93.
24. Duru K, Farrow S, Wang J. Frequency of deletion polymorphism in the gene for ACE is increased in African Americans with hypertension. Am J Hypertens. 1994;7:759-62.
25. Chiang FT, Chern TH, Lai ZP. Age and gender dependent association of ACE gene with essential hypertension in a Chinese population. J Hum Hypertens. 1996;10:823-6.
26. Morise T, Takeguchi Y, Takeda R. ACE polymorphism and essential hypertension. Lancet. 1994;343:125.
27. Nakno Y, Oshima T, Hiraga H. Genotype of ACE is a risk factor for early onset of essential hypertension Japanese population. J Lab Clin Med. 1998;13:502-6.
28. Morshed Mahboob. Association between ACE polymorphism and hypertension in selected individuals of Bangladeshi populations. J Biochem Mol Biol. 2002;35(3):251-4.
29. Alaatin Y. No association between deletion type ACE gene polymorphism and left ventricular hypertrophy in hemodialysis patients. Nephron. 2000;84:130-5.
30. Maguchi M. ACE polymorphism in essential hypertensive patients in Japanese population. Angiology. 1996;47(7):643-8.
31. Pamies AE, Palmero PC, Garcia LR. Effect of angiotensinogen M235T and the ACE I/D polymorphism on arterial hypertension and cardiovascular risk factors. Med Clin. 1999;113(51):164-8.
32. Dazida G, Sobatyl J, Puzniak A. Polymorphism of ACE and Ang II receptor type I gene in essential hypertension in Polish population. Clin Res. 2001;7:1236-41.